Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection

BACKGROUND: Minimal residual disease (MRD) is considered an essential factor leading to relapse within 2 years (early relapse) after radical surgery, which is challenging to be detected by conventional imaging. Circulating tumor DNA (ctDNA) provides a novel approach for detecting MRD and predicting...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuyan, Cai, Jianpeng, Zhong, Kaihang, Wen, Yaohong, Cai, Lei, He, Guolin, Liao, Hangyu, Zhang, Cheng, Fu, Shunjun, Chen, Tingting, Cai, Jinping, Zhong, Xuefeng, Chen, Chunzhu, Huang, Mengli, Cheng, Yuan, Pan, Mingxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028131/
https://www.ncbi.nlm.nih.gov/pubmed/36959801
http://dx.doi.org/10.3389/fonc.2023.1119744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028131/
https://www.ncbi.nlm.nih.gov/pubmed/36959801
http://dx.doi.org/10.3389/fonc.2023.1119744

Ejemplares similares